News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
631,627 Results
Type
Article (60811)
Company Profile (90)
Press Release (570726)
Section
Business (173574)
Career Advice (2717)
Deals (32395)
Drug Delivery (86)
Drug Development (76741)
Employer Resources (148)
FDA (14883)
Job Trends (13870)
News (304701)
Policy (28974)
Tag
Academia (2870)
Alliances (42855)
Alzheimer's disease (1161)
Approvals (14814)
Artificial intelligence (122)
Bankruptcy (280)
Best Places to Work (10712)
Breast cancer (106)
Cancer (925)
Career advice (2298)
Cell therapy (214)
Clinical research (60600)
Collaboration (321)
Compensation (98)
COVID-19 (2514)
C-suite (91)
Cystic fibrosis (77)
Data (882)
Diabetes (125)
Diagnostics (5906)
Drug pricing (78)
Earnings (58135)
Employer resources (131)
Events (91631)
Executive appointments (262)
FDA (15335)
Funding (287)
Gene therapy (152)
GLP-1 (538)
Government (4389)
Healthcare (18108)
Infectious disease (2583)
Inflammatory bowel disease (101)
Interviews (522)
IPO (14581)
Job creations (3431)
Job search strategy (1942)
Layoffs (437)
Legal (6436)
Lung cancer (147)
Manufacturing (145)
Medical device (12454)
Medtech (12459)
Mergers & acquisitions (17894)
Metabolic disorders (337)
Neuroscience (1391)
NextGen Class of 2024 (6365)
Non-profit (4318)
Northern California (1134)
Obesity (192)
Opinion (201)
Patents (94)
People (58392)
Phase I (18989)
Phase II (26733)
Phase III (19571)
Pipeline (243)
Postmarket research (2470)
Preclinical (8125)
Radiopharmaceuticals (238)
Rare diseases (187)
Real estate (5984)
Regulatory (19334)
Research institute (2385)
Resumes & cover letters (405)
Southern California (1026)
Startups (3335)
United States (10850)
Vaccines (525)
Weight loss (143)
Date
Today (229)
Last 7 days (839)
Last 30 days (2993)
Last 365 days (32498)
2024 (28200)
2023 (36357)
2022 (46636)
2021 (51619)
2020 (50797)
2019 (44889)
2018 (34133)
2017 (30801)
2016 (30143)
2015 (35509)
2014 (28430)
2013 (24998)
2012 (26264)
2011 (26521)
2010 (24994)
Location
Africa (868)
Arizona (134)
Asia (37351)
Australia (6706)
California (2516)
Canada (1082)
China (196)
Colorado (120)
Connecticut (115)
Europe (86641)
Florida (376)
Georgia (99)
Illinois (322)
Indiana (161)
Kansas (87)
Maryland (510)
Massachusetts (1941)
Michigan (144)
Minnesota (211)
New Jersey (793)
New York (771)
North Carolina (678)
Northern California (1134)
Ohio (121)
Pennsylvania (678)
South America (1173)
Southern California (1026)
Texas (366)
Utah (84)
Washington State (292)
631,627 Results for "university of maryland baltimore".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
CraniUS™ Awarded Competitive $1 Million Grant from the State of Maryland’s Build Our Future Innovation Infrastructure Program
CraniUS™, an R&D company focused on groundbreaking diagnostics and treatments for patients with chronic brain disease, has been awarded a competitive $1 million grant from the State of Maryland as part of Governor Wes Moore’s Build Our Future Innovation Infrastructure Pilot Program.
June 26, 2024
·
2 min read
Deals
Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 Million
Emergent BioSolutions Inc. announced that it has entered into a definitive agreement to sell its drug product facility in Baltimore-Camden to an affiliate of Bora Pharmaceuticals Co., Ltd., a leading international pharmaceutical services company, for a total value of approximately $30 million.
June 20, 2024
·
4 min read
BioCapital
Maryland Stem Cell Research Commission Announces $15.4 Million in Awards to Accelerate Cures
The Maryland Stem Cell Research Commission is pleased to announce the next round of awards granting a total of more than $15.4 million.
May 14, 2024
·
6 min read
BioCapital
Maryland Stem Cell Research Commission Announces Release of Requests for Applications for its Grant Programs
The Maryland Stem Cell Research Commission announces the release of Requests for Applications for the Maryland Stem Cell Research Fund’s first funding cycle of fiscal year 2025.
May 30, 2024
·
4 min read
Drug Development
University of Maryland and BioGenCell Announce the Launch of BioGenCell Fifth Chronic Limb-Threatening Ischemia Clinical Trial Site in the United States
BioGenCell, a pioneer in personalized cell therapy solutions, is excited to announce the launch of its fifth Phase II clinical trial site in the United States at the University of Maryland.
December 7, 2023
·
2 min read
BioCapital
Precision for Medicine Opens Expanded State-of-the-Art Biomarker Research and Companion Diagnostic Laboratory in Frederick, Maryland
Precision for Medicine, a global leader in biomarker-driven clinical research and development supporting life sciences companies, announced the completion of a major expansion to its laboratory campus in Frederick, Maryland.
May 14, 2024
·
3 min read
Business
Emergent BioSolutions Finalizes Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals
August 20, 2024
·
3 min read
BioCapital
Seraxis Wins Maryland Stem Cell Research Fund Grant to Accelerate Development of Allogenetically Compatible Pancreatic Islet Replacement Therapy for Functional Cure of T1D
Seraxis, Inc., a regenerative medicine company developing pancreatic islet replacement therapies to transform the lives of patients with Type 1 and insulin-requiring Type 2 diabetes, has been notified that the company is the awardee of a $400,000 Commercialization Program grant from the Maryland Stem Cell Research Fund that aims to foster Maryland research to enhance and propel stem cell treatments.
June 14, 2024
·
3 min read
Business
Internationally Recognized Thoracic Oncologist Dr. Taofeek K. Owonikoko Named Executive Director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
University of Maryland School of Medicine Dean Mark T. Gladwin, MD, and University of Maryland Medical Center President and CEO Bert W. O’Malley, MD, announced that Taofeek K. Owonikoko, MD, PhD, a distinguished physician-scientist with a global reputation in thoracic oncology, has been appointed Executive Director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center.
October 4, 2023
·
14 min read
Press Releases
MilliporeSigma Opens New €290 Million Biosafety Testing Facility in Rockville, Maryland, USA
October 10, 2024
·
4 min read
1 of 63,163
Next